Evicenter

Datroway (datopotamab deruxtecan-dlnk) in HR-positive HER2-negative breast cancer

Manufacturer
Daiichi Sankyo, Inc.; AstraZeneca Pharmaceuticals LP
Prescribing information
Datroway (opens in a new tab)
Questions
42
Last updated

All products

42 questions · 8 sources

Indication3 questions · 2 sources

Pharmacology4 questions · 2 sources

Clinical trials5 questions · 4 sources

Safety10 questions · 3 sources

Specific populations5 questions · 1 source

Drug interactions1 question · 1 source

Dosing and administration6 questions · 2 sources

Storage and supply2 questions · 2 sources

Access and coverage6 questions · 2 sources